Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene.

K. Yamauchi-Takihara, C. Nakajima-Taniguchi, H. Matsui, Y. Fujio, K. Kunisada, S. Nagata, T. Kishimoto

Department of Medicine III, Osaka University Medical School, Japan.

OBJECTIVE: The disease-bearing genes for hypertrophic cardiomyopathy (HCM) in HCM families have been identified as the beta-myosin heavy chain, alpha-tropomyosin, and cardiac troponin T genes. Three HCM kindreds with three distinct point mutations in the alpha-tropomyosin gene had extensive clinical evaluations. DESIGN AND RESULTS: Single-strand conformation polymorphism gel analysis of polymerase chain reaction amplified products was used to capture each of the nine exons from the alpha-tropomyosin gene to identify mutations in 60 familial HCM patients. Two missense mutations in exon 2 (Ala63Val and Lys70Thr) and one missense mutation in exon 5 (Asp175Asn) were found in three unrelated HCM kindreds. These kindreds were the subject of clinical, electrocardiographic and echocardiographic studies. The morphological appearance of HCM was similar in the three kindreds. All the patients had severe hypertrophy of the left ventricle with asymmetrical septal hypertrophy during the early stage of the disease, which gradually progressed to dilatation of the left ventricle. Moreover, these kindreds showed similar disease penetrance, age of onset, and incidence of premature sudden death. The disease in these kindreds was severe and resulted in frequent sudden deaths. CONCLUSIONS: Among Japanese patients with familial HCM mutations in the alpha-tropomyosin gene are not as rare as reported, accounting for about 5% of all cases. These mutations are characterised by hypertrophy of the left ventricle which then progresses to dilatation and a high incidence of sudden or disease-related death.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Ochala, J., Li, M., Ohlsson, M., Oldfors, A., Larsson, L. (2008). Defective regulation of contractile function in muscle fibres carrying an E41K {beta}-tropomyosin mutation. J. Physiol. 586: 2993-3004 [Abstract] [Full Text]  
• Morimoto, S. (2008). Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 77: 659-666 [Abstract] [Full Text]  
• Gunning, P., O'neill, G., Hardeman, E. (2008). Tropomyosin-Based Regulation of the Actin Cytoskeleton in Time and Space. Physiol. Rev. 88: 1-35 [Abstract] [Full Text]  
• Sipola, P., Lauerma, K., Jaaskelainen, P., Laakso, M., Peuhkurinen, K., Manninen, H., Aronen, H. J., Kuusisto, J. (2005). Cine MR Imaging of Myocardial Contractile Impairment in Patients with Hypertrophic Cardiomyopathy Attributable to Asp175Asn Mutation in the {alpha}-Tropomyosin Gene. Radiology 236: 815-824 [Abstract] [Full Text]  
• Thaman, R, Gimeno, J R, Murphy, R T, Kubo, T, Sachdev, B, Mogensen, J, Elliott, P M, McKenna, W J (2005). Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy. Heart 91: 920-925 [Abstract] [Full Text]  
• Maron, B. J., Seidman, J.G., Seidman, C. E. (2004). Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 44: 2125-2132 [Abstract] [Full Text]  
• Karkkainen, S., Helio, T., Jaaskelainen, P., Miettinen, R., Tuomainen, P., Ylitalo, K., Kaartinen, M., Reissell, E., Toivonen, L., Nieminen, M. S., Kuusisto, J., Laakso, M., Peuhkurinen, K. (2004). Two novel mutations in the {beta}-myosin heavy chain gene associated with dilated cardiomyopathy. Eur J Heart Fail 6: 861-868 [Abstract] [Full Text]  
• Wernicke, D., Thiel, C., Duja-Isac, C. M., Essin, K. V., Spindler, M., Nunez, D. J. R., Plehm, R., Wessel, N., Hammes, A., Edwards, R.-J., Lippoldt, A., Zacharias, U., Stromer, H., Neubauer, S., Davies, M. J., Morano, I., Thierfelder, L. (2004). {alpha}-Tropomyosin mutations Asp175Asn and Glu180Gly affect cardiac function in transgenic rats in different ways. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287: R685-R695 [Abstract] [Full Text]  
• Coutu, P., Bennett, C. N., Favre, E. G., Day, S. M., Metzger, J. M. (2004). Parvalbumin Corrects Slowed Relaxation in Adult Cardiac Myocytes Expressing Hypertrophic Cardiomyopathy-Linked {alpha}-Tropomyosin Mutations. Circ. Res. 94: 1235-1241 [Abstract] [Full Text]  
• Heller, M. J., Nili, M., Homsher, E., Tobacman, L. S. (2003). Cardiomyopathic Tropomyosin Mutations That Increase Thin Filament Ca2+ Sensitivity and Tropomyosin N-domain Flexibility. J. Biol. Chem. 278: 41742-41748 [Abstract] [Full Text]  
• Van Driest, S. L., Ellsworth, E. G., Ommen, S. R., Tajik, A. J., Gersh, B. J., Ackerman, M. J. (2003). Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy * Note Added in Proof. Circulation 108: 445-451 [Abstract] [Full Text]  
• Jongbloed, R. J., Marcelis, C. L., Doevendans, P. A., Schmeitz-Mulkens, J. M., Van Dockum, W. G., Geraedts, J. P., Smeets, H. J. (2003). Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy. J Am Coll Cardiol 41: 981-986 [Abstract] [Full Text]  
• Michele, D. E., Coutu, P., Metzger, J. M. (2002). Divergent abnormal muscle relaxation by hypertrophic cardiomyopathy and nemaline myopathy mutant tropomyosins. Physiol. Genomics 9: 103-111 [Abstract] [Full Text]  
• Hernandez, O. M., Housmans, P. R., Potter, J. D. (2001). Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation. J. Appl. Physiol. 90: 1125-1136 [Abstract] [Full Text]  
• Karibe, A., Tobacman, L. S., Strand, J., Butters, C., Back, N., Bachinski, L. L., Arai, A. E., Ortiz, A., Roberts, R., Homsher, E., Fananapazir, L. (2001). Hypertrophic Cardiomyopathy Caused by a Novel {{alpha}}-Tropomyosin Mutation (V95A) Is Associated With Mild Cardiac Phenotype, Abnormal Calcium Binding to Troponin, Abnormal Myosin Cycling, and Poor Prognosis. Circulation 103: 65-71 [Abstract] [Full Text]  
• MOOLMAN-SMOOK, J., DE LANGE, W., CORFIELD, V., BRINK, P. (2000). Expression of HCM causing mutations: lessons learnt from genotype-phenotype studies of the South African founder MYH7 A797T mutation. J. Med. Genet. 37: 951-956 [Full Text]  
• Evans, C. C., Pena, J. R., Phillips, R. M., Muthuchamy, M., Wieczorek, D. F., Solaro, R. J., Wolska, B. M. (2000). Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 279: H2414-H2423 [Abstract] [Full Text]  
• Regitz-Zagrosek, V., Erdmann, J., Wellnhofer, E., Raible, J., Fleck, E. (2000). Novel Mutation in the {alpha}-Tropomyosin Gene and Transition From Hypertrophic to Hypocontractile Dilated Cardiomyopathy. Circulation 102 : e112-e116 [Full Text]  
• Sorajja, P., Elliott, P.M., Mckenna, W.J. (2000). The molecular genetics of hypertrophic cardiomyopathy: prognostic implications. Europace 2: 4-14  
• Redwood, C. S., Moolman-Smook, J. C., Watkins, H. (1999). Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res 44: 20-36 [Abstract] [Full Text]  
• Jaaskelainen, P., Soranta, M., Miettinen, R., Saarinen, L., Pihlajamaki, J., Silvennoinen, K., Tikanoja, T., Laakso, M., Kuusisto, J. (1998). The cardiac {beta}-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. J Am Coll Cardiol 32: 1709-1716 [Abstract] [Full Text]  
• Bonne, G., Carrier, L., Richard, P., Hainque, B., Schwartz, K. (1998). Familial Hypertrophic Cardiomyopathy : From Mutations to Functional Defects. Circ. Res. 83: 580-593 [Abstract] [Full Text]